- Global Pharma News & Resources

Paediatric Vaccine Market to Reach USD 68.78 billion, globally, at 9.80% CAGR During the Forecast Period 2029

Paediatric Vaccines refer to the preparation consisting of dead microorganisms, fully virulent organisms, or live attenuated organisms. They are administered for stimulating the production of antibodies that further provide immunity against one or several diseases among children. Paediatric vaccines are generally utilized in childhood immunization schedules with the purpose of improving child’s immunity or prevent diseases.

Paediatric Vaccine Market report with its market research studies help anticipate next move of the competitors while keeping business in a better position to avert any possible damage from their end. Market research can help identify markets and geographical areas where business can expand to. It can also help to invest in ideas that have the most potential to succeed based on what customers are looking for and what the market is lacking. For any retail company, conducting market research can be useful to make out locations where the store can profit the most.

The paediatric vaccines are used to prevent children from contracting several infectious and non-infectious diseases. The prevalence of chronic diseases is escalating the growth of paediatric vaccine market.

Global paediatric vaccine market was valued at USD 35.74 billion in 2021 and is expected to reach USD 68.78 billion by 2029, registering a CAGR of 9.80% during the forecast period of 2022-2029. The market report curated by the Data Bridge Market Research team includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

Get PDF Sample of Paediatric Vaccine Market report: –

Paediatric Vaccine Market Dynamics

This section deals with understanding the market drivers, advantages, opportunities, restraints and challenges. All of this is discussed in detail as below:

Prevalence of Various Diseases

The increase in the prevalence of numerous diseases, such as pertussis, influenza, diphtheria, and tetanus, pertussis, among other infectious and non-infectious diseases in children acts as one of the major factors driving the growth of paediatric vaccine market.

Initiatives by Government

The rise in government and non-government funding for the development of novel vaccines and surge in initiatives for raising awareness regarding immunization accelerate the market growth.

Global Vaccination Coverage

The surge in uptake of new vaccines has leading to an increase in global vaccination coverage further influence the market.


Furthermore, increase in the number of approvals for vaccines extend profitable opportunities to the market players in the forecast period of 2022 to 2029. Also, advancements in the development of vaccines will further expand the market.

Global Paediatric Vaccine Market Scope and Market Size

The paediatric vaccine market is segmented on the basis of vaccine type, technology and application. The growth amongst these segments will help you analyse meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Vaccine Type




Live Attenuated





Other Technologies


Infectious Disease



Pneumococcal Disease


Measles, Mumps, and Rubella (MMR)

Other Applications

Gain More Insights into the Paediatric Vaccine Market Analysis, Browse Summary of the Research Report@

Paediatric Vaccine Market Regional Analysis/Insights

The paediatric vaccine market is analysed and market size insights and trends are provided by country, vaccine type, technology and application as referenced above.

The countries covered in the paediatric vaccine market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America dominates the paediatric vaccine market because of the surge in research and development investments by numerous companies within the region.

Asia-Pacific (APAC) is expected to witness significant growth during the forecast period of 2022 to 2029 due to the rise in government support for immunization in the region.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter’s five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.

Competitive Landscape and Paediatric Vaccine Market Share Analysis

The paediatric vaccine market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies’ focus related to paediatric vaccine market.

Some of the major players operating in the paediatric vaccine market are:

Incyte (US)

SINOVAC (China),


Astellas Pharma Inc. (Japan)

Novo Nordisk A/S (Denmark)

Grifols, S.A. (Spain)

Pfizer Inc. (US)

Johnson & Johnson Services, Inc. (US)

Sanofi (France)

Teva Pharmaceutical Industries Ltd. (Jerusalem)

Takeda Pharmaceutical Company Limited. (Japan)

Astrazeneca (UK)

Bristol-Myers Squibb Company (US)

GlaxoSmithKline plc (US)

Hoffmann-La Roche Ltd (Switzerland)

Novartis AG (Switzerland)

Lily (US)

Abbott (US)

Merck & Co., Inc., (US)

Get TOC details of Paediatric Vaccine Market Report: –

Key Pointers Covered in the Paediatric Vaccine Market Industry Trends and Forecast to 2029

Market Size

Market New Sales Volumes

Market Replacement Sales Volumes

Market By Brands

Market Procedure Volumes

Market Product Price Analysis

Market Regulatory Framework and Changes

Market Shares in Different Regions

Recent Developments for Market Competitors

Market Upcoming Applications

Market Innovators Study


What is the Future Market Value for Paediatric Vaccine Market?

What is the Growth Rate of the Paediatric Vaccine Market?

What are the Major Companies Operating in the Paediatric Vaccine Market?

Which Countries Data is covered in the Paediatric Vaccine Market?

What are the Main Data Pointers Covered in Paediatric Vaccine Market Report?

Top Trending Reports: –

Global Men’s Health Market – Industry Analysis and Forecast 2029
Global Personal Health Devices Market – Industry Analysis and Forecast 2029
Global Meningococcal Disease Vaccine Market – Industry Trends and Forecast to 2029
Global Wellness Supplements Market – Industry Trends and Forecast to 2029

 Global Healthcare Chatbots Market– Industry Trends and Forecast to 2028 

About Data Bridge Market Research:

An absolute way to forecast what future holds is to comprehend the trend today! Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavours to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process. Data Bridge is an aftermath of sheer wisdom and experience which was formulated and framed in the year 2015 in Pune.

Data Bridge Market Research has over 500 analysts working in different industries. We have catered more than 40% of the fortune 500 companies globally and have a network of more than 5000+ clientele around the globe. Data Bridge adepts in creating satisfied clients who reckon upon our services and rely on our hard work with certitude. We are content with our glorious 99.9 % client satisfying rate.

Contact Us:-

Data Bridge Market Research

US: +1 888 387 2818

UK: +44 208 089 1725

Hong Kong: +852 8192 7475


Editor Details

  • Company:
    • The Wire Times
Last Updated: 14-Nov-2022